{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:39:00Z","timestamp":1791268740097,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Science and Engineering Research Council of Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41429-019-0153-4","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T02:03:57Z","timestamp":1550023437000},"page":"253-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Synthesis and antibiotic activity of novel acylated phloroglucinol compounds against methicillin-resistant Staphylococcus aureus"],"prefix":"10.1038","volume":"72","author":[{"given":"Navriti","family":"Mittal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haben H.","family":"Tesfu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia T.","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1648-2310","authenticated-orcid":false,"given":"John L.","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"153_CR1","first-page":"48","volume":"113","author":"JM Munita","year":"2017","unstructured":"Munita JM, Shelburne S, Greenberg DE, Arias CA. The growing threat of antimicrobial resistance. Tex Med. 2017;113:48\u201352.","journal-title":"Tex Med"},{"key":"153_CR2","unstructured":"Public Health Agency of Canada. Canadian antimicrobial resistance surveillance system 2017 Report. 2017."},{"key":"153_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2200","volume":"7","author":"HF Chambers","year":"2009","unstructured":"Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7:629\u201341.","journal-title":"Nat Rev Microbiol"},{"key":"153_CR4","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1093\/cid\/cit613","volume":"58","author":"ME Stryjewski","year":"2014","unstructured":"Stryjewski ME, Corey GR. Methicillin-resistant Staphylococcus aureus: an evolving pathogen. Clin Infect Dis. 2014;58:S10\u2013S19.","journal-title":"Clin Infect Dis"},{"key":"153_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.idc.2008.10.002","volume":"23","author":"LG Miller","year":"2009","unstructured":"Miller LG, Kaplan SL. Staphylococcus aureus: a community pathogen. Infect Dis Clin North Am. 2009;23:35\u201352.","journal-title":"Infect Dis Clin North Am"},{"issue":"S3","key":"153_CR6","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1002\/ppul.24139","volume":"53","author":"Nour Akil","year":"2018","unstructured":"Akil N, Muhlebach MS. Biology and management of methicillin resistant Staphylococcus aureus in cystic fibrosis. Pediatr Pulmonol. 2018. \n                    https:\/\/doi.org\/10.1002\/ppul.24139","journal-title":"Pediatric Pulmonology"},{"key":"153_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/cid\/cir399","volume":"53","author":"C Gangell","year":"2011","unstructured":"Gangell C, et al. Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis. Clin Infect Dis. 2011;53:425\u201332.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"153_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1089\/mdr.2017.0162","volume":"24","author":"Paula Pena Amaya","year":"2018","unstructured":"Pena Amaya P, et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients from Argentina. Microb Drug Resist. 2017. \n                    https:\/\/doi.org\/10.1089\/mdr.2017.0162","journal-title":"Microbial Drug Resistance"},{"key":"153_CR9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/MCP.0000000000000422","volume":"23","author":"MS Muhlebach","year":"2017","unstructured":"Muhlebach MS. Methicillin-resistant Staphylococcus aureus in cystic fibrosis: how should it be managed? Curr Opin Pulm Med. 2017;23:544\u201350.","journal-title":"Curr Opin Pulm Med"},{"key":"153_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd4510","volume":"14","author":"AL Harvey","year":"2015","unstructured":"Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015;14:111\u201329.","journal-title":"Nat Rev Drug Discov"},{"key":"153_CR11","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1248\/cpb.17.2054","volume":"17","author":"T Heihachiro","year":"1969","unstructured":"Heihachiro T, Ushio S, Shoji S. Biosynthesis of natural products.VI) Biosynthesis of usnic acid in lichen\u2019s (1). A general scheme of biosynthesis of usnic acid. Chem Pharma. 1969;17:2054\u201360.","journal-title":"Chem Pharma"},{"key":"153_CR12","first-page":"1673","volume":"13","author":"R Sarkar","year":"2018","unstructured":"Sarkar R, Mittal N, Sorensen J, Sen T. A comparison of the bioactivity of usnic acid versus methylphloracetophenone. Nat Prod Commun. 2018;13:1673\u20136.","journal-title":"Nat Prod Commun"},{"key":"153_CR13","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1089\/mdr.2017.0162","volume":"24","author":"P Pena Amaya","year":"2018","unstructured":"Pena Amaya P, et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients from Argentina. Microb Drug Resist. 2018;24:613\u201320.","journal-title":"Microb Drug Resist"},{"key":"153_CR14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1086\/381972","volume":"38","author":"GA Pankey","year":"2004","unstructured":"Pankey GA, Sabath LD. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin Infect Dis. 2004;38:864\u201370.","journal-title":"Clin Infect Dis"},{"key":"153_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-018-0278-9","volume":"559","author":"AR Brochado","year":"2018","unstructured":"Brochado AR, et al. Species-specific activity of antibacterial drug combinations. Nature. 2018;559:259\u201363.","journal-title":"Nature"},{"key":"153_CR16","first-page":"252","volume":"19","author":"JM Sahuquillo Arce","year":"2006","unstructured":"Sahuquillo Arce JM. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus. Rev Esp Quimioterap. 2006;19:252\u20137.","journal-title":"prous Sci"},{"key":"153_CR17","unstructured":"Clinical and Laboratory Standards Institute CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 9th ed. CLSI; Wayne, USA, 2012."},{"key":"153_CR18","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.ejmech.2017.10.044","volume":"143","author":"E Zhang","year":"2018","unstructured":"Zhang E, et al. Synthesis and bioactivities study of new antibacterial peptide mimics: the dialkyl cationic amphiphiles. Eur J Med Chem. 2018;143:1489\u2013509.","journal-title":"Eur J Med Chem"},{"key":"153_CR19","first-page":"137","volume-title":"Methods in Molecular Biology","author":"Isobelle M. Evie","year":"2017","unstructured":"Evie IM, Dickson AJ, Elvin M. Metabolite profiling of mammalian cell culture processes to evaluate cellular viability. In: Gilbert DF, Friedrich O, editors. Cell viability assays: methods and protocols. New York: Springer; 2017. p. 137\u201352."},{"key":"153_CR20","unstructured":"Garcia Lynne S. Clinical microbiology procedures handbook, vols. 1\u20133. 3rd ed. ASM Press, Washington, DC, 2016."},{"key":"153_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/jac\/dku342","volume":"70","author":"A Belkum van","year":"2015","unstructured":"van Belkum A, et al. Meropenem\/colistin synergy testing for multidrug-resistant Acinetobacter baumannii strains by a two-dimensional gradient technique applicable in routine microbiology. J Antimicrob Chemother. 2015;70:167\u201372.","journal-title":"J Antimicrob Chemother"},{"key":"153_CR22","doi-asserted-by":"publisher","first-page":"e01231","DOI":"10.1128\/AAC.01231-18","volume":"62","author":"AM Hogan","year":"2018","unstructured":"Hogan AM, et al. Competitive fitness of essential gene knockdowns reveals a broad-spectrum antibacterial inhibitor of the cell division protein FtsZ. Antimicrob Agents Chemother. 2018;62:e01231\u201318.","journal-title":"Antimicrob Agents Chemother"},{"key":"153_CR23","doi-asserted-by":"publisher","first-page":"e0128587","DOI":"10.1371\/journal.pone.0128587","volume":"10","author":"C Selin","year":"2015","unstructured":"Selin C, et al. A pipeline for screening small molecules with growth inhibitory activity against Burkholderia cenocepacia. PLoS One. 2015;10:e0128587.","journal-title":"PLoS One"},{"key":"153_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2180-10-124","volume":"10","author":"D Sperandio","year":"2010","unstructured":"Sperandio D, et al. Cell-associated hemolysis activity in the clinical strain of Pseudomonas fluorescens MFN1032. BMC Microbiol. 2010;10:124.","journal-title":"BMC Microbiol"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41429-019-0153-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-019-0153-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-019-0153-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:31:49Z","timestamp":1684603909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-019-0153-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["153"],"URL":"https:\/\/doi.org\/10.1038\/s41429-019-0153-4","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"14 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}